Status:

WITHDRAWN

Botulinum Toxin and Saliva Management in Tracheotomised Patients

Lead Sponsor:

HCA International Limited

Conditions:

Traumatic Brain Injury

Eligibility:

All Genders

18+ years

Phase:

PHASE2

Brief Summary

TITLE A randomised placebo controlled trial to explore the effectiveness of Botulinum Toxin injection at reducing oral secretions and frequency of tracheal suctioning in tracheotomised patients. DES...

Detailed Description

A randomised placebo controlled trial to explore the effectiveness of Botulinum Toxin injection at reducing oral secretions and frequency of tracheal suctioning in tracheotomised patients. Protocol N...

Eligibility Criteria

Inclusion

  • Patients must meet all of the following inclusion criteria to be eligible for enrollment into the study
  • Male or female participants over the age of 18 years
  • Participants who have a tracheostomy tube in-situ
  • Participants who are breathing on room air, without the need for any mechanical ventilation
  • Participants who require tracheal suctioning in order to maintain a clear airway

Exclusion

  • Patients presenting with any of the following exclusion criteria will not be included in the study
  • Contra-indications to the use of Botulinum Toxin
  • Receiving medications that may react with Botulinum Toxin, such as aminoglycosides (e.g., gentamicin), anticholinesterase medicines (e.g., neostigmine), lincosamides (e.g., clindamycin), magnesium, neuromuscular blockers (e.g., atracurium), polymyxin, or quinidine because the risk of toxic effects may be increased
  • Receiving anticoagulants medication (e.g., warfarin)
  • Expectant mothers
  • Previous history of:
  • Swallowing disorders
  • Stroke
  • Myocardial Infarction
  • Heart Disease
  • Head or neck surgery
  • Acute or progressive neurological disease
  • Structural abnormalities that may affect swallowing

Key Trial Info

Start Date :

September 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 1 2011

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT00973999

Start Date

September 1 2009

End Date

September 1 2011

Last Update

September 6 2012

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

The Wellington Hospital

London, United Kingdom, NW8 9LE

Botulinum Toxin and Saliva Management in Tracheotomised Patients | DecenTrialz